Skip to main content

Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes.

Publication ,  Journal Article
Akbik, F; Alawieh, A; Dimisko, L; Howard, BM; Cawley, CM; Tong, FC; Nahab, F; Samuels, OB; Maier, I; Feng, W; Goyal, N; Starke, RM; Rai, A ...
Published in: J Neurointerv Surg
October 2022

BACKGROUND: Atrial fibrillation (AF) associated ischemic stroke is associated with worse functional outcomes, less effective recanalization, and increased rates of hemorrhagic complications after intravenous thrombolysis (IVT). Conversely, AF is not associated with hemorrhagic complications or functional outcomes in patients undergoing mechanical thrombectomy (MT). This differential effect of MT and IVT in AF associated stroke raises the question of whether bridging thrombolysis increases hemorrhagic complications in AF patients undergoing MT. METHODS: This international cohort study of 22 comprehensive stroke centers analyzed patients with large vessel occlusion (LVO) undergoing MT between June 1, 2015 and December 31, 2020. Patients were divided into four groups based on comorbid AF and IVT exposure. Baseline patient characteristics, complications, and outcomes were reported and compared. RESULTS: 6461 patients underwent MT for LVO. 2311 (35.8%) patients had comorbid AF. In non-AF patients, bridging therapy improved the odds of good 90 day functional outcomes (adjusted OR (aOR) 1.29, 95% CI 1.03 to 1.60, p=0.025) and did not increase hemorrhagic complications. In AF patients, bridging therapy led to significant increases in symptomatic intracranial hemorrhage and parenchymal hematoma type 2 (aOR 1.66, 1.07 to 2.57, p=0.024) without any benefit in 90 day functional outcomes. Similar findings were noted in a separate propensity score analysis. CONCLUSION: In this large thrombectomy registry, AF patients exposed to IVT before MT had increased hemorrhagic complications without improved functional outcomes, in contrast with non-AF patients. Prospective trials are warranted to assess whether AF patients represent a subgroup of LVO patients who may benefit from a direct to thrombectomy approach at thrombectomy capable centers.

Duke Scholars

Published In

J Neurointerv Surg

DOI

EISSN

1759-8486

Publication Date

October 2022

Volume

14

Issue

10

Start / End Page

979 / 984

Location

England

Related Subject Headings

  • Treatment Outcome
  • Thrombolytic Therapy
  • Thrombectomy
  • Stroke
  • Prospective Studies
  • Mechanical Thrombolysis
  • Humans
  • Fibrinolytic Agents
  • Cohort Studies
  • Brain Ischemia
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Akbik, F., Alawieh, A., Dimisko, L., Howard, B. M., Cawley, C. M., Tong, F. C., … Stroke Thrombectomy and Aneurysm Registry (STAR) Collaborators. (2022). Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes. J Neurointerv Surg, 14(10), 979–984. https://doi.org/10.1136/neurintsurg-2021-017954
Akbik, Feras, Ali Alawieh, Laurie Dimisko, Brian M. Howard, C Michael Cawley, Frank C. Tong, Fadi Nahab, et al. “Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes.J Neurointerv Surg 14, no. 10 (October 2022): 979–84. https://doi.org/10.1136/neurintsurg-2021-017954.
Akbik F, Alawieh A, Dimisko L, Howard BM, Cawley CM, Tong FC, et al. Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes. J Neurointerv Surg. 2022 Oct;14(10):979–84.
Akbik, Feras, et al. “Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes.J Neurointerv Surg, vol. 14, no. 10, Oct. 2022, pp. 979–84. Pubmed, doi:10.1136/neurintsurg-2021-017954.
Akbik F, Alawieh A, Dimisko L, Howard BM, Cawley CM, Tong FC, Nahab F, Samuels OB, Maier I, Feng W, Goyal N, Starke RM, Rai A, Fargen KM, Psychogios MN, Jabbour P, De Leacy R, Keyrouz SG, Dumont TM, Kan P, Liman J, Arthur AS, Wolfe SQ, Mocco J, Crosa RJ, Fox WC, Gory B, Spiotta AM, Grossberg JA, Stroke Thrombectomy and Aneurysm Registry (STAR) Collaborators. Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes. J Neurointerv Surg. 2022 Oct;14(10):979–984.

Published In

J Neurointerv Surg

DOI

EISSN

1759-8486

Publication Date

October 2022

Volume

14

Issue

10

Start / End Page

979 / 984

Location

England

Related Subject Headings

  • Treatment Outcome
  • Thrombolytic Therapy
  • Thrombectomy
  • Stroke
  • Prospective Studies
  • Mechanical Thrombolysis
  • Humans
  • Fibrinolytic Agents
  • Cohort Studies
  • Brain Ischemia